Completed Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma NCT05813470 Conditions Allergic Asthma, Asthma, Bronchial Diseases, +8 more Locations Golestan Hospital — Ahvāz, Iran Imam Khomeini — Ahvāz, Iran Khorshid Hospital — Isfahan, Iran Dr.Tavakoul Office — Karaj, Iran View all 22 locations View more locations Show fewer locations Loading locations... View Trial Details
